Table 1.
Participant(s) | Years HIV-1-infected | CD4 count (/mm3) | Viral Load (copies/ml) | CD8 Epitope | HAART |
---|---|---|---|---|---|
Pt 1 | 11 | 950 | <50 | B27/gag/KRWIILGLNK | no |
Pt 2 | 5 months | 560 | >500,000 | B8/nef/FLKEKGGL | no |
Pt 3 | 9 | 820 | 158 | A*0201/gag/SLYNTVATL | no |
Pt 4 | 2 | 330 | 200,000 | A*0201/gag/SLYNTVATL | no |
Pt 5–7 | HIV-1 negative | NA | NA | A*0201/EBV/GLCLVAML | NA |
NA=not applicable
HAART= highly active anti-retroviral therapy